Insights

Strategic partnership There is a collaboration with Tiziana Life Sciences on inhalation delivery tech for COVID-19 treatment, suggesting Sciarra Laboratories is open to joint development opportunities with pharma players and contract research/manufacturing partners.

Early stage funding Revenue is under one million, indicating a startup or early-stage operation. This may present a door for low-volume, high-margin manufacturing, early supplier contracts, and trial-scale partnerships.

Niche inhalation focus Involvement in inhalation delivery for lung treatment points to expertise or interest in specialized formulation and device integration, offering opportunities to supply APIs, excipients, or contract manufacturing for inhalation products.

Limited headcount Employee count at 0-1 suggests a highly lean operation; sales outreach could emphasize end-to-end CDMO services, regulatory support, and scalable production solutions to enable rapid onboarding.

Tech-enabled operations Technology stack includes modern web and UI frameworks, indicating a digitally capable partner; leverage for showcasing capabilities, API access for supply chain, and remote collaboration in manufacturing projects.

Similar companies to Sciarra Laboratories Inc

Sciarra Laboratories Inc Tech Stack

Sciarra Laboratories Inc uses 8 technology products and services including Network Solutions, Google Fonts API, AngularJS, and more. Explore Sciarra Laboratories Inc's tech stack below.

  • Network Solutions
    Domain Name Services
  • Google Fonts API
    Font Scripts
  • AngularJS
    Javascript Frameworks
  • Choices
    Javascript Libraries
  • Lua
    Programming Languages
  • HSTS
    Security
  • Kendo UI
    UI Frameworks
  • Nginx
    Web Servers

Sciarra Laboratories Inc's Email Address Formats

Sciarra Laboratories Inc uses at least 2 email formats:
Sciarra Laboratories Inc Email FormatsExamplePercentage
First.Last@sciarralabs.comJohn.Doe@sciarralabs.com
88%
First@sciarralabs.comJohn@sciarralabs.com
12%

Frequently Asked Questions

What is Sciarra Laboratories Inc's official website and social media links?

Minus sign iconPlus sign icon
Sciarra Laboratories Inc's official website is sciarralabs.com and has social profiles on LinkedIn.

How much revenue does Sciarra Laboratories Inc generate?

Minus sign iconPlus sign icon
As of August 2026, Sciarra Laboratories Inc's annual revenue is estimated to be <$1M.

What is Sciarra Laboratories Inc's NAICS code?

Minus sign iconPlus sign icon
Sciarra Laboratories Inc's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sciarra Laboratories Inc have currently?

Minus sign iconPlus sign icon
As of August 2026, Sciarra Laboratories Inc has approximately 1 employees across 1 continents, including North America. Key team members include Office Manager: S. B. and Principal: R. S. Explore Sciarra Laboratories Inc's employee directory with LeadIQ.

What industry does Sciarra Laboratories Inc belong to?

Minus sign iconPlus sign icon
Sciarra Laboratories Inc operates in the Pharmaceutical Manufacturing industry.

What technology does Sciarra Laboratories Inc use?

Minus sign iconPlus sign icon
Sciarra Laboratories Inc's tech stack includes Network Solutions, Google Fonts API, AngularJS, Choices, Lua, HSTS, Kendo UI and Nginx.

What is Sciarra Laboratories Inc's email format?

Minus sign iconPlus sign icon
Sciarra Laboratories Inc's email format typically follows the pattern of First.Last@sciarralabs.com. Find more Sciarra Laboratories Inc email formats with LeadIQ.
Sciarra Laboratories Inc logo

Sciarra Laboratories Inc

Pharmaceutical ManufacturingNew York, United States0-1 Employees

Sciarra Laboratories Inc operates in the pharmaceutical manufacturing sector from its base in Hicksville, New York. The company is described as a consumer goods firm with a focus on collaborative development projects, including a partnership with Tiziana Life Sciences to advance inhalation delivery of a therapeutic for COVID-19 through a handheld device or nebulizer. This indicates involvement in specialized drug delivery research and development, likely targeting respiratory treatment applications. The organization appears to be small in scale, with a notable recent development being the partnership reported in mid-2020 that links Sciarra Laboratories with another biotech firm to explore direct lung delivery technologies.

Historically, the company's activities situate it within the broader pharmaceutical manufacturing ecosystem, where collaborations and technology development play a central role in expanding delivery methods for therapies. Based in the New York metropolitan area, Sciarra Laboratories centers its operations on advancing inhalation-based administration, potentially addressing needs in clinical and consumer health contexts through joint research efforts.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
0-1

Section iconFunding & Financials

  • <$1M

    Sciarra Laboratories Inc's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.